XML 33 R74.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Apr. 03, 2019
Mar. 31, 2019
Aug. 09, 2018
Feb. 03, 2016
Nov. 02, 2015
Operating Loss Carryforwards [Line Items]                
Deferred tax assets, valuation allowance $ 139,855 $ 135,216            
Change in valuation allowance 4,600              
Net change in valuation allowance, recorded as tax expense 2,899 16,360 $ (24,976)          
Undistributed earnings of foreign subsidiaries 100              
Income tax (benefit) expense $ (4,725) $ 284 $ (459)          
Effective tax rate (6.80%)              
State and Local Jurisdiction                
Operating Loss Carryforwards [Line Items]                
Operating loss carryforwards, state and local $ 217,100              
State and Local Jurisdiction | Research Tax Credit Carryforward                
Operating Loss Carryforwards [Line Items]                
Tax credit carryforward amount 15,900              
State and Local Jurisdiction | TriVascular Technologies, Inc.                
Operating Loss Carryforwards [Line Items]                
Decrease in net operating loss carryforwards             $ 209,400  
Internal Revenue Service (IRS)                
Operating Loss Carryforwards [Line Items]                
Operating loss carryforwards, domestic 350,800              
Federal alternative minimum tax credit carryforwards 100              
Internal Revenue Service (IRS) | Research Tax Credit Carryforward                
Operating Loss Carryforwards [Line Items]                
Tax credit carryforward amount 10,200              
Internal Revenue Service (IRS) | TriVascular Technologies, Inc.                
Operating Loss Carryforwards [Line Items]                
Decrease in net operating loss carryforwards             230,300  
Internal Revenue Service (IRS) | TriVascular Technologies, Inc. | Research Tax Credit Carryforward                
Operating Loss Carryforwards [Line Items]                
Decrease in research and development credits             $ 3,100  
Income Tax Expense (Benefit)                
Operating Loss Carryforwards [Line Items]                
Net change in valuation allowance, recorded as tax expense 2,900              
Income Tax Expense (Benefit) | State and Local Jurisdiction                
Operating Loss Carryforwards [Line Items]                
Net change in valuation allowance, recorded as tax expense 1,700              
Convertible notes                
Operating Loss Carryforwards [Line Items]                
Income tax (benefit) expense $ 5,000              
Convertible Senior Notes Due 2020                
Operating Loss Carryforwards [Line Items]                
Debt instrument, stated interest rate 3.25%         3.25%    
Convertible Senior Notes Due 2020 | Convertible notes                
Operating Loss Carryforwards [Line Items]                
Debt instrument, stated interest rate           3.25%   3.25%
5% Note | Convertible notes                
Operating Loss Carryforwards [Line Items]                
Debt instrument, stated interest rate       5.00% 5.00%